09:44 AM EST, 01/10/2025 (MT Newswires) -- Xeris Biopharma Holdings ( XERS ) said Friday it now expects 2024 revenue of $203 million, compared with its prior guidance of between $198 million and $202 million.

Analysts polled by FactSet expect $199.7 million.

The company said it expects Q4 revenue of $60 million.

Analysts surveyed by FactSet expect $56.7 million.

Price: 3.38, Change: +0.02, Percent Change: +0.60